MSOS

AdvisorShares Pure US Cannabis ETF

Fundamental data last updated:June 4, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Financial Services

industry

Asset Management

Exchange

AMEX

County of HQ

US

Next Earnings Date

Not Scheduled

Business Summary

The First U.S.-Listed ETF Available – MSOS is the first actively managed U.S.-listed ETF with dedicated cannabis exposure focusing exclusively on U.S. companies, including multi-state operators. The portfolio manager allocates across an investable universe of U.S. companies spanning a variety of cannabis-related businesses. Easy Access to U.S. Cannabis Exposure – MSOS trades on the NYSE Arca exchange, offering exposure to multiple cannabis securities in a convenient, single trade. To buy U.S. cannabis companies on your own, investors will need to seek these stocks out in smaller, foreign exchanges. Experience – MSOS’ portfolio manager has deep experience in the capital markets and well-established expertise investing in highly-regulated areas in the equity markets, including cannabis. MSOS assets are held by one of the largest U.S. custodial banks, BNY Mellon.

 


Analyze MSOS on TradingView

VALUATION

P/E

N/A

Market Cap ($M USD)

$744.16M

Forward P/E

N/A

PEG

N/A

PRICE TO SALES

N/A

PRICE TO BOOK

N/A

EV / EBITDA

N/A

5-Year Average P/E

Free Cash Flow Yield

N/A

DCF Value

N/A

Graham Number

N/A

Price to FCF

N/A

EV to FCF

N/A

Earnings Yield

N/A

FCF Yield

N/A

DIVIDEND

Yield

N/A

Annual Payout

N/A

Payout Ratio

N/A

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

N/A

Next Year EPS Growth Estimate

N/A

Next Year Revenue Growth Estimate

N/A

Return on Equity (ROE)

N/A

FREE CASH FLOW

Operating Margin

N/A

Debt-to-Equity

N/A

Piotroski F-Score

N/A

Altman Z-Score

N/A

Return on Invested Capital (ROIC)

N/A

Current Ratio

N/A

Quick Ratio

N/A

Net Debt to EBITDA

N/A

Interest Coverage

N/A

Gross Profit margin

N/A

FCF PER SHARE

N/A

REVENUE PER SHARE

N/A

Analyze MSOS on TradingView

Gainseekers Quantitative Analysis

Summary

The market seems to be navigating in the dark with MSOS AdvisorShares Pure US Cannabis ETF. With a snapshot price that has recently been extended above its 50-Day and 200-Day SMAs, the stock appears technically overextended. The absence of critical valuation metrics like Forward P/E, Earnings Yield, and Altman Z-score leaves investors without a clear picture of its safety and growth potential. The lack of a DCF Value and Graham Number further complicates any definitive valuation assessment. This ETF is a puzzle with missing pieces, making it a risky proposition for those seeking clarity and stability.

AI Exposure / Tech Reliance

As an asset management entity within the Financial Services sector, MSOS is uniquely positioned to leverage AI and modern tech shifts. The industry is increasingly adopting AI for portfolio management and risk assessment, potentially enhancing efficiency. However, without specific data on its tech adoption, the ETF's resilience to these shifts remains speculative.

The Bull Case

For a value or GARP investor, the allure of MSOS might be its potential for growth in the burgeoning cannabis sector. However, without concrete metrics like ROIC, FCF Yield, or Piotroski F-Score, it's challenging to craft a compelling narrative about its pricing power or capital efficiency. The ETF's appeal lies more in the sector's promise than in its current financial metrics.

The Bear Case

The glaring absence of key financial metrics is the Achilles' heel of MSOS. With no data on Price/Book, Price/Sales, or cash flow, investors are left in the dark about its valuation and liquidity. The stock's proximity to its 52-week high suggests a technical overextension, raising concerns about its current pricing. This lack of transparency and potential overvaluation could deter risk-averse investors.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

N/A

Average Analyst Price Target

N/A

Institutional Ownership %

1-Year Beta

0.87

Insider Buying % (6 Mo)

Distance to 52-Week High

41.60%

Distance to 52-Week Low

59.77%

EARNINGS SURPRISE %

N/A

50-DAY SMA

$4.34

200-DAY SMA

$4.41

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.